ReviewAesthetic surgery journal. Open forum2023
Botulinum Toxin Type A for the Treatment of Masseter Muscle Prominence in Asian Populations.
Review in Aesthetic surgery journal. Open forum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 10 citations in OpenAlex.
- Comparison of the effectiveness of botulinum toxin, dry needling, pharmacological treatment, and manual therapy for bruxism-induced myalgia: a prospective randomized study.Journal of oral & facial pain and headache · 2024Trial
- Article
- Article
- Anatomical Mapping of the Masseter for Safe Botulinum Toxin Injection: A Cadaveric Study.BioMed research international · 2026Article
- A Novel Injection Technique to Prevent Exacerbation of Sunken Cheek After Botulinum Toxin Type A Treatment for Masseter Hypertrophy: A Prospective Clinical Study.Journal of cosmetic dermatology · 2025Article
- Effect of Facial Acupuncture Stimulation: MRI-Based Masseter Muscle Volume Analysis and Questionnaire Evaluation.Aesthetic surgery journal. Open forum · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Asian populations, an oval face shape with a slimmer lower face is considered favorable. Botulinum toxin type A (BoNT-A) treatment of the lower face for aesthetic purposes is widely performed in Asia, although it is not officially approved for this indication in any country. In this review, the authors highlight recent research describing injection techniques, mechanism of action, clinical efficacy, and key learning points to safely treat benign masseter muscle prominence (MMP) in Asian populations using BoNT-A. To support the existing literature, clinical examples are provided that demonstrate individualized treatment plans for patients with asymmetric vs symmetric MMP and an observed complication after treatment. This review provides insights for optimizing clinical outcomes and for designing future studies investigating the safety and efficacy of BoNT-A for treating MMP. Level of Evidence 5:
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.